We are live on !
Find out more
Column Group Portfolio holdings
AUM
$88.1M
Turnover
0%
1-Year Est. Return
148.03%
This Fund
S&P 500
This Quarter Est. Return
-12.48%
1 Year Est. Return
+148.03%
3 Year Est. Return
+95.12%
5 Year Est. Return
+23.89%
10 Year Est. Return
–
AUM
$88.1M
AUM Growth
-$12.6M
(-13%)
Cap. Flow
$0
Cap. Flow % of AUM
Cap. Flow %
0%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
3
New
–
Increased
–
Reduced
–
Closed
–
Avg Time Held
5.3
years
Top 10 Avg Time Held
5.3
years
Top 20 Avg Time Held
5.3
years
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Surrozen
SRZN
$603M
| $49.7M | 56.46% |
1,916,950
| – | – |
2021 Q3
19 quarters
|
|
2
Oric Pharmaceuticals
ORIC
$815M
| $38.3M | 43.53% |
3,540,777
| – | – |
2020 Q4
22 quarters
|
|
3
Revolution Medicines
RVMD
$37.3B
| $8.62K | 0.01% |
46
| – | – |
2020 Q4
22 quarters
|
|
Similar funds
KFP
HI
Column Group's Q2 2026 Portfolio in Review
As of Q2 2026, Column Group held 3 positions worth $88.1M, down 13% from $101M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Trading was light in Q2 2026: portfolio turnover was 0%. Column Group opened no new positions and made no exits, leaving the 3-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- Column Group's ten largest holdings make up 100% of its $88.1M portfolio in Q2 2026.
- Column Group opened 0 new positions and closed 0 in Q2 2026.
- Column Group's portfolio value fell 13% quarter-over-quarter to $88.1M.
Based on Column Group's 13F filing for Q2 2026, filed 14 Aug 2026.